Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.

Quercetin and 2-Methoxyestradiol (2-ME) are promising anti-cancer substances. Our previous in vitro study showed that quercetin synergized with 2-Methoxyestradiol exhibiting increased antiproliferative and proapoptotic activity in both androgen-dependent LNCaP and androgen-independent PC-3 human pro...

Full description

Bibliographic Details
Main Authors: Feiya Yang, Liming Song, Huiping Wang, Jun Wang, Zhiqing Xu, Nianzeng Xing
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4444352?pdf=render
_version_ 1828785396034568192
author Feiya Yang
Liming Song
Huiping Wang
Jun Wang
Zhiqing Xu
Nianzeng Xing
author_facet Feiya Yang
Liming Song
Huiping Wang
Jun Wang
Zhiqing Xu
Nianzeng Xing
author_sort Feiya Yang
collection DOAJ
description Quercetin and 2-Methoxyestradiol (2-ME) are promising anti-cancer substances. Our previous in vitro study showed that quercetin synergized with 2-Methoxyestradiol exhibiting increased antiproliferative and proapoptotic activity in both androgen-dependent LNCaP and androgen-independent PC-3 human prostate cancer cell lines. In the present study, we determined whether their combination could inhibit LNCaP and PC-3 xenograft tumor growth in vivo and explored the underlying mechanism. Human prostate cancer LNCaP and PC-3 cells were inoculated subcutaneously in male BALB/c nude mice. When xenograft tumors reached about 100 mm3, mice were randomly allocated to vehicle control, quercetin or 2-Methoxyestradiol singly treated and combination treatment groups. After therapeutic intervention for 4 weeks, combination treatment of quercetin and 2-ME i) significantly inhibited prostate cancer xenograft tumor growth by 46.8% for LNCaP and 51.3% for PC-3 as compared to vehicle control group, more effective than quercetin (28.4% for LNCaP, 24.8% for PC3) or 2-ME (32.1% for LNCaP, 28.9% for PC3) alone; ii) was well tolerated by BALB/c mice and no obvious toxic reactions were observed; iii) led to higher Bax/Bcl-2 ratio, cleaved caspase-3 protein expression and apoptosis rate; and iv) resulted in lower phosphorylated AKT (pAKT) protein level, vascular endothelial growth factor protein and mRNA expression, microvascular density and proliferation rate than single drug treatment. These effects were more remarkable compared to vehicle group. Therefore, combination of quercetin and 2-ME can serve as a novel clinical treatment regimen owning the potential of enhancing antitumor effect on prostate cancer in vivo and lessening the dose and side effects of either quercetin or 2-ME alone. These in vivo results will lay a further solid basis for subsequent researches on this novel therapeutic regimen in human prostate cancer.
first_indexed 2024-12-11T23:50:20Z
format Article
id doaj.art-b4e5feffba5d472ca046295b6457afc6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T23:50:20Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b4e5feffba5d472ca046295b6457afc62022-12-22T00:45:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012827710.1371/journal.pone.0128277Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.Feiya YangLiming SongHuiping WangJun WangZhiqing XuNianzeng XingQuercetin and 2-Methoxyestradiol (2-ME) are promising anti-cancer substances. Our previous in vitro study showed that quercetin synergized with 2-Methoxyestradiol exhibiting increased antiproliferative and proapoptotic activity in both androgen-dependent LNCaP and androgen-independent PC-3 human prostate cancer cell lines. In the present study, we determined whether their combination could inhibit LNCaP and PC-3 xenograft tumor growth in vivo and explored the underlying mechanism. Human prostate cancer LNCaP and PC-3 cells were inoculated subcutaneously in male BALB/c nude mice. When xenograft tumors reached about 100 mm3, mice were randomly allocated to vehicle control, quercetin or 2-Methoxyestradiol singly treated and combination treatment groups. After therapeutic intervention for 4 weeks, combination treatment of quercetin and 2-ME i) significantly inhibited prostate cancer xenograft tumor growth by 46.8% for LNCaP and 51.3% for PC-3 as compared to vehicle control group, more effective than quercetin (28.4% for LNCaP, 24.8% for PC3) or 2-ME (32.1% for LNCaP, 28.9% for PC3) alone; ii) was well tolerated by BALB/c mice and no obvious toxic reactions were observed; iii) led to higher Bax/Bcl-2 ratio, cleaved caspase-3 protein expression and apoptosis rate; and iv) resulted in lower phosphorylated AKT (pAKT) protein level, vascular endothelial growth factor protein and mRNA expression, microvascular density and proliferation rate than single drug treatment. These effects were more remarkable compared to vehicle group. Therefore, combination of quercetin and 2-ME can serve as a novel clinical treatment regimen owning the potential of enhancing antitumor effect on prostate cancer in vivo and lessening the dose and side effects of either quercetin or 2-ME alone. These in vivo results will lay a further solid basis for subsequent researches on this novel therapeutic regimen in human prostate cancer.http://europepmc.org/articles/PMC4444352?pdf=render
spellingShingle Feiya Yang
Liming Song
Huiping Wang
Jun Wang
Zhiqing Xu
Nianzeng Xing
Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
PLoS ONE
title Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
title_full Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
title_fullStr Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
title_full_unstemmed Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
title_short Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
title_sort combination of quercetin and 2 methoxyestradiol enhances inhibition of human prostate cancer lncap and pc 3 cells xenograft tumor growth
url http://europepmc.org/articles/PMC4444352?pdf=render
work_keys_str_mv AT feiyayang combinationofquercetinand2methoxyestradiolenhancesinhibitionofhumanprostatecancerlncapandpc3cellsxenografttumorgrowth
AT limingsong combinationofquercetinand2methoxyestradiolenhancesinhibitionofhumanprostatecancerlncapandpc3cellsxenografttumorgrowth
AT huipingwang combinationofquercetinand2methoxyestradiolenhancesinhibitionofhumanprostatecancerlncapandpc3cellsxenografttumorgrowth
AT junwang combinationofquercetinand2methoxyestradiolenhancesinhibitionofhumanprostatecancerlncapandpc3cellsxenografttumorgrowth
AT zhiqingxu combinationofquercetinand2methoxyestradiolenhancesinhibitionofhumanprostatecancerlncapandpc3cellsxenografttumorgrowth
AT nianzengxing combinationofquercetinand2methoxyestradiolenhancesinhibitionofhumanprostatecancerlncapandpc3cellsxenografttumorgrowth